Business

Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary

Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class AFebruary 24, 20264
Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary

About this update from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

Announcement on Progress in Signing the Licensing Agreement of Wholly-owned Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

More from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

All Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A news →